Testing JNJ-1761981 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This early-stage trial tests a new drug called JNJ-1761981 in people with solid tumors (cancers that form in organs or tissues, excluding brain tumors) that have spread or returned after standard treatment. The study aims to find the right dose and see how well the drug works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor (not brain/CNS cancer) that is locally advanced or metastatic (spread to other parts of body)
- Your cancer has progressed after standard treatment, or you cannot tolerate standard treatments, or there is no standard treatment available
- Your overall health and ability to perform daily activities meets a specific score (ECOG 0 or 1, meaning you can do most activities)
- You are willing to use two highly effective methods of birth control during the study and for 11–14 months after your last study drug dose
- You do not have active cancer in your brain or central nervous system
- You do not have a bleeding disorder or need anticoagulation that cannot be paused for procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, JNJ-87704916, given alone or with other treatments for people with advanced solid tumors that have stopped responding to standard therapies. It may be an option if you have a tumor that can be injected and are in good overall health.
This trial tests a new investigational drug (JNJ-87890387) for people with certain advanced solid tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
This trial tests a new drug called JNJ-89862175 for people with certain advanced solid tumors, including lung adenocarcinoma, kidney cancer, ovarian cancer, and uterine cancer. The goal is to see if this treatment is safe and effective.
This trial tests a new drug, JNJ-95437446, in people with certain advanced cancers (non-small cell lung, colorectal, or head and neck cancer). The goal is to see if it can help shrink or control the cancer.
This trial tests two new drugs, JS212 and JS213, alone or together, for people with certain advanced cancers that have stopped responding to standard treatments. The goal is to see if these drugs can shrink tumors or slow cancer growth.
This trial tests a new drug, CM518D1, for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and effective, and may offer a new option for those who have few choices left.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.